MetaVia Inc. is trading 4.1% down at $2.57, continuing a sharp pullback from a late-May rally as investors assess financing and listing risks ahead of key events.
- The company announced today that senior management will present an update on its obesity and metabolic therapies pipeline at the Emerging Growth Conference on June 11, 2026.
- The stock has been under pressure since releasing positive, but early-stage, clinical data on May 27, with investors looking ahead to a June 8 shareholder vote that includes a proposal for a reverse stock split.